Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

A retrospective evaluation of adjunctive risperidone treatment in severely behaviorally disordered boys receiving psychosocial treatment.

Caldwell MF, Malterer M, Umstead D, McCormick DJ.

J Child Adolesc Psychopharmacol. 2008 Feb;18(1):34-43. doi: 10.1089/cap.2007.0013.

PMID:
18294087
2.
3.

[Metabolic side effects of risperidone in early onset schizophrenia].

Goeb JL, Marco S, Duhamel A, Kechid G, Bordet R, Thomas P, Delion P, Jardri R.

Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1. French.

PMID:
20620267
4.
5.

Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.

Snyder R, Turgay A, Aman M, Binder C, Fisman S, Carroll A; Risperidone Conduct Study Group.

J Am Acad Child Adolesc Psychiatry. 2002 Sep;41(9):1026-36.

PMID:
12218423
6.

Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ.

Findling RL, Aman MG, Eerdekens M, Derivan A, Lyons B; Risperidone Disruptive Behavior Study Group.

Am J Psychiatry. 2004 Apr;161(4):677-84.

PMID:
15056514
7.

Risperidone versus haloperidol in children and adolescents with AD : a randomized, controlled, double-blind trial.

Miral S, Gencer O, Inal-Emiroglu FN, Baykara B, Baykara A, Dirik E.

Eur Child Adolesc Psychiatry. 2008 Feb;17(1):1-8. Epub 2007 Dec 13.

PMID:
18080171
8.

Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study.

Troost PW, Lahuis BE, Steenhuis MP, Ketelaars CE, Buitelaar JK, van Engeland H, Scahill L, Minderaa RB, Hoekstra PJ.

J Am Acad Child Adolesc Psychiatry. 2005 Nov;44(11):1137-44.

PMID:
16239862
9.

Use of risperidone in a paediatric population: an observational study.

King B, Zwi K, Nunn K, Longworth J, Dossetor D.

J Paediatr Child Health. 2003 Sep-Oct;39(7):523-7.

PMID:
12969207
10.

Clinical overview of children with mucopolysaccharidosis type III A and effect of Risperidone treatment on children and their mothers psychological status.

Kalkan Ucar S, Ozbaran B, Demiral N, Yuncu Z, Erermis S, Coker M.

Brain Dev. 2010 Feb;32(2):156-61. doi: 10.1016/j.braindev.2008.12.010. Epub 2009 Feb 12.

PMID:
19217229
11.

Prolactin levels during long-term risperidone treatment in children and adolescents.

Findling RL, Kusumakar V, Daneman D, Moshang T, De Smedt G, Binder C.

J Clin Psychiatry. 2003 Nov;64(11):1362-9.

PMID:
14658952
12.

Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial.

Ghaleiha A, Mohammadi E, Mohammadi MR, Farokhnia M, Modabbernia A, Yekehtaz H, Ashrafi M, Hassanzadeh E, Akhondzadeh S.

Paediatr Drugs. 2013 Dec;15(6):505-14. doi: 10.1007/s40272-013-0036-2.

PMID:
23821414
13.

Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.

Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F.

Pediatrics. 2004 Nov;114(5):e634-41. Epub 2004 Oct 18.

PMID:
15492353
14.

A retrospective chart review of risperidone use in treatment-resistant children and adolescents with psychiatric disorders.

Simeon J, Milin R, Walker S.

Prog Neuropsychopharmacol Biol Psychiatry. 2002 Feb;26(2):267-75. Review.

PMID:
11817503
15.

Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder.

MacMillan CM, Withney JE, Korndörfer SR, Tilley CA, Mrakotsky C, Gonzalez-Heydrich JM.

J Psychiatr Pract. 2008 May;14(3):160-9. doi: 10.1097/01.pra.0000320115.38434.16.

PMID:
18520785
16.

[Treatment of behavioral disorders by risperidone in children with autism].

Wei BY, Huang F, Qin XT, Liang QQ.

Zhongguo Dang Dai Er Ke Za Zhi. 2011 Mar;13(3):216-8. Chinese.

17.

Treating disruptive behavior disorders with risperidone: a 1-year, open-label safety study in children and adolescents.

Haas M, Karcher K, Pandina GJ.

J Child Adolesc Psychopharmacol. 2008 Aug;18(4):337-45. doi: 10.1089/cap.2007.0098.

PMID:
18759643
18.

Risperidone in children with disruptive behavior disorders and subaverage intelligence: a 1-year, open-label study of 504 patients.

Croonenberghs J, Fegert JM, Findling RL, De Smedt G, Van Dongen S; Risperidone Disruptive Behavior Study Group.

J Am Acad Child Adolesc Psychiatry. 2005 Jan;44(1):64-72.

PMID:
15608545
19.

The effectiveness of risperidone in the treatment of three children with feeding disorders.

Berger-Gross P, Coletti DJ, Hirschkorn K, Terranova E, Simpser EF.

J Child Adolesc Psychopharmacol. 2004 Winter;14(4):621-7.

PMID:
15662156
20.

A 3-year naturalistic study of 53 preschool children with pervasive developmental disorders treated with risperidone.

Masi G, Cosenza A, Mucci M, Brovedani P.

J Clin Psychiatry. 2003 Sep;64(9):1039-47.

PMID:
14628979

Supplemental Content

Support Center